1. Sun, Guangshun, Zhao, Siqi, Fan, Zhongguo, Gao, Yun, Tang, Weiwei. 2023. CHSY1 promotes CD8+ T cell exhaustion through activation of succinate metabolism pathway leading to colorectal cancer liver metastasis based on CRISPR/Cas9 screening. In Journal of experimental & clinical cancer research : CR, 42, 248. doi:10.1186/s13046-023-02803-0. https://pubmed.ncbi.nlm.nih.gov/37749638/
2. Sher, Gulab, Naeem, Muhammad. 2013. A novel CHSY1 gene mutation underlies Temtamy preaxial brachydactyly syndrome in a Pakistani family. In European journal of medical genetics, 57, 21-4. doi:10.1016/j.ejmg.2013.11.001. https://pubmed.ncbi.nlm.nih.gov/24269551/
3. Lyu, Zhaojie, Da, Yifeng, Liu, Hongkai, Zhu, Yong, Tian, Jing. 2022. Chsy1 deficiency reduces extracellular matrix productions and aggravates cartilage injury in osteoarthritis. In Gene, 827, 146466. doi:10.1016/j.gene.2022.146466. https://pubmed.ncbi.nlm.nih.gov/35390446/
4. Liu, Jingjing, Tian, Zhenwei, Liu, Tianzhou, Liu, Yuanda, Zhu, Jiaming. 2021. CHSY1 is upregulated and acts as tumor promotor in gastric cancer through regulating cell proliferation, apoptosis, and migration. In Cell cycle (Georgetown, Tex.), 20, 1861-1874. doi:10.1080/15384101.2021.1963553. https://pubmed.ncbi.nlm.nih.gov/34412565/
5. Liu, Chiung-Hui, Lan, Chyn-Tair, Chou, Jui-Feng, Tseng, To-Jung, Liao, Wen-Chieh. 2017. CHSY1 promotes aggressive phenotypes of hepatocellular carcinoma cells via activation of the hedgehog signaling pathway. In Cancer letters, 403, 280-288. doi:10.1016/j.canlet.2017.06.023. https://pubmed.ncbi.nlm.nih.gov/28652022/
智鼠故事 
